NOT-DA-03-020: ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®


ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM

Release Date:  July 1, 2002

NOTICE:  NOT-DA-03-020

RFP AVAILABLE:  N01DA-3-8829

National Institute on Drug Abuse (NIDA)

The National Institute on Drug Abuse (NIDA) is soliciting proposals 
from qualified organizations having in-house capability to perform: (a) 
bio-analytical methods development and validation (b) quantitative drug 
analyses in biological specimens (c) federal good laboratory compliance 
requirements and (d) shipping and handling of biological specimens.  
NIDA and NIDA sponsored investigators use the data obtained for 
submissions to the FDA. The reports shall be adequate in format and 
substance for submission to the FDA in support of IND and NDA 
applications.  Offerors must indicate possession of current DEA 
registration for Schedule II-V substances prior to award and apply for 
Schedule I registration at the time of award.

NIDA anticipates the award of a 5 year incrementally funded completion-
type contract with optional quantities from this procurement.  

All offerors must comply with the FDA"s Good Laboratory Practices 
Program.

NIDA anticipates the release of RFP No. N01DA-3-8829 on or about July 
15, 2002, with responses due 45 calendar days thereafter.  Offerors can 
access the RFP through the FedBizOpps (URL: http://www.fedbizopps.gov 
or through the NIDA website at the following address: (URL: 
http://www.nida.nih.gov/RFP/RFPList.html). NIDA will issue a 
streamlined RFP for this acquisition.  Streamlined RFPs include only 
the Work Statement, Deliverables, Reporting Requirements, Special 
Requirements, Mandatory Qualifications, Technical Evaluation Criteria, 
and other necessary Proposal Preparation Instructions. The streamlined 
RFP contains all the information required for the submission of an 
offer.  Following proposal submission and the initial review process, 
the Contracting Officer may require additional documentation from 
offerors comprising the competitive range.  The due date for responses 
to the RFP is on or about August 29, 2002. This advertisement does not 
commit the Government to award a contract.  

Point of Contact:  Michelle L. Scala, Contract Specialist
                   National Institute on Drug Abuse, NIH
                   Contracts Management Branch, OPRM
                   6001 Executive Boulevard
                   Room 3105, MSC 9543
                   Bethesda, Maryland  20892-9543
                   Electronic Mail Address:  [email protected]
                   Telephone:  (301) 443-6677
                   Fax:  (301) 443-7595
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices